Dengue Testing Market is valued at USD 480.9 Million in 2018 and expected to reach USD 742.4 Million by 2025 with the CAGR of 6.4% over the forecast period. Introduction of cost-effective and reliable test kits and devices are anticipated to drive the growth of Global Dengue Testing Market.
Dengue is the most rapidly spreading mosquito-borne viral disease in the world. Blood testing detects the dengue virus or antibodies produced in response to dengue infection. To control the spread of dengue fever, reduce the number of deaths and prevent its reoccurrence in the future, governments across the world have adopted various comprehensive dengue control policies that basically focus on prevention and cure. Various countries have set up their own national programs such as the National Dengue Prevention and Control Program in countries such as Indonesia, Brazil, India and Philippines. The World Mosquito Program, formerly known as Eliminate Dengue is helping to protect the global population from mosquito-borne diseases. Such types of interventions are boosting the global dengue testing market all over the world.
Get Sample Copy of This Premium Report@ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=57377&RequestType=Sample
On the basis of product type dengue testing market segmented into ELISA-based tests, RT-PCR based tests and dengue IgG/IgM rapid test. On the basis of application, dengue testing market segmented into hospitals, public health laboratory, diagnostic centers and others.
The regions covered in this Global Dengue Testing Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of dengue testing is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Key Players for Dengue Testing Market Reports-
The major key player of dengue testing market are Abbott Laboratories, NovaTec Immundiagnostica GmbH, Euroimmun AG (PerkinElmer), Quest Diagnostics, OriGene Technologies Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Certest Biotech S.L., Abnova Corporation and InBios International, Inc.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=57377&RequestType=Methodology
Increase Incidences of Dengue Fever is the Key Factors to Propel the Global Dengue Testing Market.
Presently, the diagnostic test kits that are available for testing dengue are less effective. Insufficient availability of effective diagnostic tools and high price of existing test kits creates the demand for cost effective test kits with high specificity and sensitivity. So, the companies operating in this market are currently focusing on the development of cost-effective and reliable test methods for dengue testing. Change in climate is likely to increase the burden of dengue fever, and this in turn will propel the growth of the market of dengue testing. However, despite the high level of awareness for dengue prevention and cure, there are various challenges such as inadequate funding and resources and a lack of sound strategy to respond to the increasing problems related to dengue outbreaks in various regions of the world. Rapid urbanization, lack of sanitation, increases in international trade and mobility of population restraint the efforts to control dengue. Moreover, Government tendering and partnerships between diagnostic kit manufacturers can provide some opportunities to the market players.
North America is Expected to Dominate the Dengue Testing Market.
On the basis of region, the dengue virus dengue testing market can be divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is sub-divided into specific countries such as the U.S., Canada, Germany, the U.K., Brazil, China, India, Japan, and GCC countries. Asia pacific is leading in global dengue testing market in 2017. Millions of cases of dengue infection occur worldwide each year. Dengue fever is most common in Southeast Asia and the western Pacific islands, but the disease has been increasing rapidly in Latin America and the Caribbean. Latin America is an emerging region of the market. The market in this region is anticipated to expand at a rapid speed during the forecast period from 2018 to 2026 owing to increasing incidences of dengue fever, improving health care industry and increase in government investment to develop better health care infrastructure.
Get Full information of This Report@ https://brandessenceresearch.biz/Lifesciences-and-Healthcare/Dengue-Testing-Market-Size/Summary
Key Benefits for Dengue Testing Market Report–
- Global market report covers in depth historical and forecast analysis.
- Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global market report helps to identify opportunities in marketplace.
- Global market report covers extensive analysis of emerging trends and competitive landscape.
Dengue Testing Market Segmentation: –
By Product Type (ELISA-Based Tests, RT-PCR Based Tests, Dengue IgG/IgM Rapid Test), By Application (Hospitals, Public Health Laboratory, Diagnostic Centers, Others)
As a leading market research reseller, we help businesses exploit market intelligence and leverage the in-depth analysis of market research to devise strategies in a competitive market. Our expertise in business domains helps us to curate and aggregate market research reports that offer a laser-like focus on the targeted segments. A slice of the market share is a hard won battle, and it takes the power of actionable insights to help businesses take timely decisions. The ‘need of the hour’ is inputs that are relevant and on time.
Contact us at: +44-2038074155 or mail us at email@example.com